UniProt ID | ARHG8_HUMAN | |
---|---|---|
UniProt AC | Q7Z628 | |
Protein Name | Neuroepithelial cell-transforming gene 1 protein | |
Gene Name | NET1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 596 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Acts as guanine nucleotide exchange factor (GEF) for RhoA GTPase. May be involved in activation of the SAPK/JNK pathway Stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death.. | |
Protein Sequence | MEPELAAQKQPRPRRRSRRASGLSTEGATGPSADTSGSELDGRCSLRRGSSFTFLTPGPNWDFTLKRKRREKDDDVVSLSSLDLKEPSNKRVRPLARVTSLANLISPVRNGAVRRFGQTIQSFTLRGDHRSPASAQKFSSRSTVPTPAKRRSSALWSEMLDITMKESLTTREIRRQEAIYEMSRGEQDLIEDLKLARKAYHDPMLKLSIMSEEELTHIFGDLDSYIPLHEDLLTRIGEATKPDGTVEQIGHILVSWLPRLNAYRGYCSNQLAAKALLDQKKQDPRVQDFLQRCLESPFSRKLDLWSFLDIPRSRLVKYPLLLKEILKHTPKEHPDVQLLEDAILIIQGVLSDINLKKGESECQYYIDKLEYLDEKQRDPRIEASKVLLCHGELRSKSGHKLYIFLFQDILVLTRPVTRNERHSYQVYRQPIPVQELVLEDLQDGDVRMGGSFRGAFSNSEKAKNIFRIRFHDPSPAQSHTLQANDVFHKQQWFNCIRAAIAPFQSAGSPPELQGLPELHEECEGNHPSARKLTAQRRASTVSSVTQVEVDENAYRCGSGMQMAEDSKSLKTHQTQPGIRRARDKALSGGKRKETLV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEPELAAQ -------CCHHHHHC | 20.48 | 22814378 | |
9 | Ubiquitination | EPELAAQKQPRPRRR CHHHHHCCCCCCCCH | 58.50 | - | |
9 | Acetylation | EPELAAQKQPRPRRR CHHHHHCCCCCCCCH | 58.50 | 25953088 | |
17 | Phosphorylation | QPRPRRRSRRASGLS CCCCCCHHHHHCCCC | 25.06 | 23898821 | |
21 | Phosphorylation | RRRSRRASGLSTEGA CCHHHHHCCCCCCCC | 38.15 | 30266825 | |
24 | Phosphorylation | SRRASGLSTEGATGP HHHHCCCCCCCCCCC | 28.12 | 30266825 | |
25 | Phosphorylation | RRASGLSTEGATGPS HHHCCCCCCCCCCCC | 43.40 | 30266825 | |
29 | Phosphorylation | GLSTEGATGPSADTS CCCCCCCCCCCCCCC | 61.56 | 30266825 | |
32 | Phosphorylation | TEGATGPSADTSGSE CCCCCCCCCCCCCCC | 39.87 | 23927012 | |
35 | Phosphorylation | ATGPSADTSGSELDG CCCCCCCCCCCCCCC | 34.40 | 30576142 | |
36 | Phosphorylation | TGPSADTSGSELDGR CCCCCCCCCCCCCCC | 40.65 | 30576142 | |
38 | Phosphorylation | PSADTSGSELDGRCS CCCCCCCCCCCCCCE | 34.45 | 23927012 | |
50 | Phosphorylation | RCSLRRGSSFTFLTP CCEECCCCCCEEECC | 22.07 | 28450419 | |
51 | Phosphorylation | CSLRRGSSFTFLTPG CEECCCCCCEEECCC | 31.00 | 28464451 | |
53 | Phosphorylation | LRRGSSFTFLTPGPN ECCCCCCEEECCCCC | 21.49 | 28464451 | |
56 | Phosphorylation | GSSFTFLTPGPNWDF CCCCEEECCCCCCCC | 23.24 | 28464451 | |
64 | Phosphorylation | PGPNWDFTLKRKRRE CCCCCCCEECCCCCC | 28.97 | - | |
78 | Phosphorylation | EKDDDVVSLSSLDLK CCCCCEEEHHHCCCC | 23.53 | 22199227 | |
80 | Phosphorylation | DDDVVSLSSLDLKEP CCCEEEHHHCCCCCC | 22.73 | 20873877 | |
81 | Phosphorylation | DDVVSLSSLDLKEPS CCEEEHHHCCCCCCC | 31.06 | 27251275 | |
85 | Ubiquitination | SLSSLDLKEPSNKRV EHHHCCCCCCCCCCC | 68.21 | - | |
99 | Phosphorylation | VRPLARVTSLANLIS CCHHHHHHHHHHHHH | 16.69 | 29978859 | |
100 | Phosphorylation | RPLARVTSLANLISP CHHHHHHHHHHHHHH | 23.72 | 26055452 | |
106 | Phosphorylation | TSLANLISPVRNGAV HHHHHHHHHHHCCHH | 22.10 | 26055452 | |
119 | Phosphorylation | AVRRFGQTIQSFTLR HHHHCHHEEEEEEEC | 22.74 | 23186163 | |
122 | Phosphorylation | RFGQTIQSFTLRGDH HCHHEEEEEEECCCC | 19.15 | 23186163 | |
124 | Phosphorylation | GQTIQSFTLRGDHRS HHEEEEEEECCCCCC | 22.31 | 24719451 | |
126 | Methylation | TIQSFTLRGDHRSPA EEEEEEECCCCCCHH | 45.49 | 115484821 | |
137 | Ubiquitination | RSPASAQKFSSRSTV CCHHHHCHHCCCCCC | 47.10 | - | |
139 | Phosphorylation | PASAQKFSSRSTVPT HHHHCHHCCCCCCCC | 31.70 | 28985074 | |
140 (in isoform 2) | Ubiquitination | - | 33.12 | 21906983 | |
140 | Phosphorylation | ASAQKFSSRSTVPTP HHHCHHCCCCCCCCC | 33.12 | 28985074 | |
142 | Phosphorylation | AQKFSSRSTVPTPAK HCHHCCCCCCCCCCH | 35.39 | 28985074 | |
149 | Ubiquitination | STVPTPAKRRSSALW CCCCCCCHHHHHHHH | 49.93 | - | |
152 | Phosphorylation | PTPAKRRSSALWSEM CCCCHHHHHHHHHHH | 24.81 | 24719451 | |
153 | Phosphorylation | TPAKRRSSALWSEML CCCHHHHHHHHHHHH | 26.10 | 28348404 | |
180 | Phosphorylation | IRRQEAIYEMSRGEQ HHHHHHHHHHHCCCH | 16.78 | - | |
183 | Phosphorylation | QEAIYEMSRGEQDLI HHHHHHHHCCCHHHH | 25.79 | - | |
194 (in isoform 1) | Ubiquitination | - | 53.04 | 21906983 | |
194 | Ubiquitination | QDLIEDLKLARKAYH HHHHHHHHHHHHHHC | 53.04 | 2190698 | |
198 | Ubiquitination | EDLKLARKAYHDPML HHHHHHHHHHCCCCH | 47.92 | - | |
241 | Ubiquitination | TRIGEATKPDGTVEQ HHHHHHCCCCCCHHH | 48.43 | - | |
274 | Ubiquitination | CSNQLAAKALLDQKK HHHHHHHHHHHHHHC | 33.68 | - | |
280 | Ubiquitination | AKALLDQKKQDPRVQ HHHHHHHHCCCHHHH | 52.66 | - | |
301 | Ubiquitination | LESPFSRKLDLWSFL HHCCCCCCCCHHHHH | 45.19 | - | |
317 | Ubiquitination | IPRSRLVKYPLLLKE CCHHHHHCHHHHHHH | 45.82 | - | |
357 | Ubiquitination | LSDINLKKGESECQY HHHCCCCCCCCHHHH | 71.70 | - | |
360 | Phosphorylation | INLKKGESECQYYID CCCCCCCCHHHHHHH | 52.95 | - | |
368 | Ubiquitination | ECQYYIDKLEYLDEK HHHHHHHHHHHHCHH | 33.39 | - | |
375 | Ubiquitination | KLEYLDEKQRDPRIE HHHHHCHHHCCCCHH | 50.75 | - | |
385 | Ubiquitination | DPRIEASKVLLCHGE CCCHHHHHEEEEECC | 43.90 | - | |
396 | Ubiquitination | CHGELRSKSGHKLYI EECCHHCCCCCEEEE | 54.76 | - | |
451 | Phosphorylation | GDVRMGGSFRGAFSN CCCCCCCCCCCCCCC | 13.17 | 24719451 | |
453 | Methylation | VRMGGSFRGAFSNSE CCCCCCCCCCCCCCH | 36.91 | 115484829 | |
489 | Ubiquitination | QANDVFHKQQWFNCI CHHHHHCHHHHHHHH | 32.49 | - | |
505 | Phosphorylation | AAIAPFQSAGSPPEL HHHHHHHHCCCCHHH | 34.67 | 30576142 | |
508 | Phosphorylation | APFQSAGSPPELQGL HHHHHCCCCHHHCCC | 36.68 | 25849741 | |
528 | Phosphorylation | ECEGNHPSARKLTAQ HHCCCCHHHHHHHHH | 32.91 | 21712546 | |
533 | Phosphorylation | HPSARKLTAQRRAST CHHHHHHHHHHHHHC | 24.63 | 22817900 | |
539 | Phosphorylation | LTAQRRASTVSSVTQ HHHHHHHHCCCCCEE | 27.77 | 27273156 | |
540 | Phosphorylation | TAQRRASTVSSVTQV HHHHHHHCCCCCEEE | 24.34 | 25159151 | |
542 | Phosphorylation | QRRASTVSSVTQVEV HHHHHCCCCCEEEEE | 21.12 | 28450419 | |
543 | Phosphorylation | RRASTVSSVTQVEVD HHHHCCCCCEEEEEC | 25.50 | 26657352 | |
545 | Phosphorylation | ASTVSSVTQVEVDEN HHCCCCCEEEEECCC | 28.92 | 26657352 | |
554 | Phosphorylation | VEVDENAYRCGSGMQ EEECCCCEECCCCCH | 20.30 | 22210691 | |
558 | Phosphorylation | ENAYRCGSGMQMAED CCCEECCCCCHHHCC | 34.42 | 23882029 | |
567 | Sumoylation | MQMAEDSKSLKTHQT CHHHCCCHHHCCCCC | 72.61 | - | |
567 | Ubiquitination | MQMAEDSKSLKTHQT CHHHCCCHHHCCCCC | 72.61 | - | |
567 | Sumoylation | MQMAEDSKSLKTHQT CHHHCCCHHHCCCCC | 72.61 | - | |
570 | Sumoylation | AEDSKSLKTHQTQPG HCCCHHHCCCCCCHH | 51.56 | - | |
570 | Sumoylation | AEDSKSLKTHQTQPG HCCCHHHCCCCCCHH | 51.56 | - | |
570 | Ubiquitination | AEDSKSLKTHQTQPG HCCCHHHCCCCCCHH | 51.56 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
100 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARHG8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARHG8_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MAGI1_HUMAN | MAGI1 | physical | 11350080 | |
DLG1_HUMAN | DLG1 | physical | 19586902 | |
MAGI1_HUMAN | MAGI1 | physical | 19586902 | |
DLG4_MOUSE | Dlg4 | physical | 17938206 | |
DLG1_MOUSE | Dlg1 | physical | 17938206 | |
DLG3_MOUSE | Dlg3 | physical | 17938206 | |
MAGI1_MOUSE | Magi1 | physical | 17938206 | |
MPP2_MOUSE | Mpp2 | physical | 17938206 | |
MPP6_MOUSE | Mpp6 | physical | 17938206 | |
CSKP_MOUSE | Cask | physical | 17938206 | |
LIN7C_MOUSE | Lin7c | physical | 17938206 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; SER-32; SER-100 ANDSER-106, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100 AND SER-106, ANDMASS SPECTROMETRY. |